Owen N. Witte
Director · Allogene Therapeutics, Inc.
Individual
- 2026
- Jun 23, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Owen N. Witte files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David D. Chang - $289K in ALLO purchases and sales in the last 12 months
- Zachary Roberts - $104K in ALLO purchases and sales in the last 12 months
- Earl Martin Douglas - $103K in ALLO purchases and sales in the last 12 months
- Geoffrey M. Parker - $88K in ALLO purchases and sales in the last 12 months
- Benjamin Machinas Beneski - $52K in ALLO purchases and sales in the last 12 months
- Annie Yoshiyama - $29K in ALLO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Owen N. Witte?
Owen N. Witte is a corporate insider, tracked as Director of Allogene Therapeutics, Inc. (ALLO). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Owen N. Witte last file a Form 4?
The only primary Form 4 on record is dated 23 June 2026.